HIV-1

Infectious Disease

29 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Approved(9)

Drug	Company
darunavir	Mylan II B.V. (MYL)
Delstrigo	Merck & Co., Inc. (MRK)
etravirine	Amneal Pharmaceuticals, Inc. (AMRX)
fosamprenavir	Mylan II B.V. (MYL)
Isentress/Isentress HD	Merck & Co., Inc. (MRK)
nevirapine	Mylan II B.V. (MYL)
paxlovid	PFIZER INC (PFE)
Pifeltro	Merck & Co., Inc. (MRK)
ritonavir	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(7)

Phase 2(5)

Drug	Company
BIC/FTC/TAF	Merck & Co., Inc. (MRK)
dapivirine	HWH International Inc. (HWH)
ISL/ULO	Merck & Co., Inc. (MRK)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
truvada	HWH International Inc. (HWH)

Phase 1(3)

Phase 2/Phase 3(5)

Drug	Company
bictegravir/emtricitabine/tenofovir alafenamide	GILEAD SCIENCES, INC. (GILD)
lenacapavir pacfosacil	GILEAD SCIENCES, INC. (GILD)
lepetegravir	GILEAD SCIENCES, INC. (GILD)
lepetegravir/lenacapavir pacfosacil fdc	GILEAD SCIENCES, INC. (GILD)
PRO 140	CytoDyn Inc. (CYDY)

BioSniper tracks 29 drugs in development for HIV-1 across 9 companies.

There are 1 clinical trial targeting HIV-1 tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.